|
 |
NIAID : Biodefense : For Researchers : Resources : Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases
Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases
RFA-AI-04-018: Letter of intent due - 8/09/2004; Applications due - 9/09/2004
Presentations from May 5, 2004 RCE Public Briefing
RCE Sites and Contact Information
US Map with RCE Regions
NIAID Contacts
Related News
In 2003, NIAID established eight Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (RCEs) throughout the United States. Each Center is comprised of a consortium of universities and complementary research institutions serving a specific geographical region. The primary objective of the Centers program is to support the NIAID Biodefense and Emerging Infectious Diseases Research Agenda. The Centers will build and maintain a strong infrastructure supporting multifaceted research and development activities that promote scientific discovery and translational research capacity required to create the next generation of therapeutics, vaccines, and diagnostics for the NIAID Category A-C agents. The goals of the Centers include:
- Develop and conduct programs of investigator-directed research.
- Train a new generation of science professionals to perform biodefense research activities.
- Develop and maintain comprehensive core facilities that support the Center's research and training activities, as well as other investigators in the region conducting NIAID biodefense research.
- Develop translational research capacity for testing and validating vaccine, therapeutic, and diagnostic concepts for relevant biodefense and emerging infectious diseases.
- Provide facilities and support to first-line responders in the event of a national biodefense emergency.
The research being conducted within the RCEs spans a broad range of biodefense and emerging infectious disease topics including:
- Basic research on bacterial and viral disease processes.
- New approaches to blocking the action of anthrax, botulinum, and cholera toxins.
- Developing new vaccines against anthrax, plague, tularemia, smallpox, and hemorrhagic fevers.
- Creating new immunization strategies and delivery systems.
- Generating new antibiotics and other therapeutics.
- Designing new advanced diagnostic methods and devices.
- Conducting immunological studies of host-pathogen interactions.
- Developing computational and genomic approaches for studying infectious diseases.
|
Institution |
Center Name |
Web Site Address |
Principal Investigator |
Region I:
Harvard Medical School |
New England Regional Center
of Excellence for Biodefense and Emerging Infectious Diseases |
http://nerce.med.harvard.edu |
Dr. Dennis Kasper |
Region II:
New York State Department of Health |
Northeast Biodefense Center |
http://www.nbc.columbia.edu/ |
Dr. W. Ian Lipkin |
Region III:
University of Maryland, Baltimore |
Mid-Atlantic Regional Center
of Excellence for Biodefense and Emerging Infectious Diseases |
http://marce.vbi.vt.edu |
Dr. Myron Levine |
Region IV:
Duke University |
Southeast Regional Center
of Excellence for Biodefense and Emerging Infectious Diseases |
http://www.serceb.org |
Dr. Barton Haynes |
Region V:
University of Chicago |
Great Lakes Regional Center
of Excellence for Biodefense and Emerging Infectious Diseases |
http://www.glrce.org |
Dr. Olaf Schneewind |
Region VI:
University of Texas Medical Branch |
Western Regional Center
of Excellence for Biodefense and Emerging Infectious Diseases |
http://rce.swmed.edu/ |
Dr. David Walker |
Region VII:
Washington University |
Midwest Regional Center
of Excellence for Biodefense and Emerging Infectious Diseases |
http://mrce.wustl.edu |
Dr. Samuel Stanley |
Region X:
University of Washington |
WWAMI (WA, WY, AK, MT, ID) Regional Center
of Excellence for Biodefense and Emerging Infectious Diseases |
http://depts.washington.edu/wwamirce/ |
Dr. Samuel Miller |
Click a map region for more detailed RCE information.
Working with dangerous bugs by Helen Quill & Maria Giovanni
Nature Immunology Volume 5 Number 8, August 2004
Biomedical Research – An Integral Component of National Security
Rona Hirschberg, PhD, John La Montagne, PhD, and Anthony S. Fauci, MD
The New England Journal of Medicine, Vol 350:2119-2121
May 20, 2004
NIAID Press Release: HHS Announces New Regional Centers for Biodefense Research, September 4, 2003
Boom, or bust?
Hundreds of millions of dollars are pouring into US biodefence research. You might expect scientists working on infectious diseases to be unequivocally delighted. But things aren’t that simple, says Erika Check.
Nature 426, 598-601 (11 December 2003)
NIH Distributes Biodefense Funds, Nancy Touchette
Genome News Network
October 17, 2003
Big Bucks for Biodefense, David Malakoff
ScienceNOW
September 8, 2003 |
|